News search

E.g., 12/10/2026
E.g., 12/10/2026
Enrique_Lara_Cardiovascular_Research
About the CNIC
1 Oct 2026

The finding, published in Cardiovascular Research, lays the groundwork for specific treatments for heart failure with preserved ejection fraction

The R33Q mutation in calsequestrin 2 (CASQ2) disrupts calcium control in heart cells and activates protein-degradation mechanisms.
Research
23 Sep 2026

Researchers at the CNIC, in collaboration with the University of Pavia and IRCCS Istituti Clinici Scientifici Maugeri, have found that activation of the enzyme calpain contributes to the development of a severe inherited arrhythmia.

Poster Antibody Responses in Health and Disease: un encuentro internacional para avanzar en el conocimiento de la inmunidad
Poster “Understanding the Neurovascular Network to Prevent Dementi
About the CNIC
4 Sep 2026

The conference “Understanding the Neurovascular Network to Prevent Dementia” will bring together leading international experts to address the role of vascular health in preventing cognitive decline and dementia

Pablo García Pavía y Nerea Mora.
Research
4 Aug 2026

Left ventricular hypertrabeculation, an anatomical feature of the heart traditionally linked to higher risk, does not worsen outcomes in patients with dilated cardiomyopathy

Research
29 Jul 2026

The findings suggest that a risk-based personalized approach may be more efficient than applying intensive surveillance protocols uniformly to all patients. 

About the CNIC
11 Jun 2026

The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease

Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
Research
22 May 2026

A CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors

Francesco Costa